SKIN (SkinHealth Systems Inc. Class A Common Stock) Stock Analysis - Analyst Ratings

SkinHealth Systems Inc. Class A Common Stock (SKIN) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, SKIN trades at $0.69 with a market cap of $78.49M and a P/E ratio of -13.92. SKIN moved +4.00% today. Year to date, SKIN is -51.95%; over the trailing twelve months it is -59.91%. Its 52-week range spans $0.55 to $2.69. Analyst consensus is neutral with an average price target of $1.63. Rallies surfaces SKIN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate SKIN?

5 analysts cover SKIN: 0 strong buy, 1 buy, 3 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $1.63.

SKIN Key Metrics

Key financial metrics for SKIN
MetricValue
Price$0.69
Market Cap$78.49M
P/E Ratio-13.92
EPS$-0.05
Dividend Yield0.00%
52-Week High$2.69
52-Week Low$0.55
Volume1
Avg Volume0
Revenue (TTM)$296.12M
Net Income$-6.05M
Gross Margin64.91%

SKIN Analyst Consensus

5 analysts cover SKIN: 0 strong buy, 1 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $1.63.

Latest SKIN News

Recent SKIN Insider Trades

  • Gruber Desiree sold 14.66K (~$22.02K) on Nov 20, 2024.
  • SAUNDERS BRENT L bought 40.45K (~$43.69K) on Aug 12, 2024.

Common questions about SKIN

What do analysts rate SKIN?
5 analysts cover SKIN: 0 strong buy, 1 buy, 3 hold, 1 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $1.63.
Does Rallies show SKIN price targets?
Yes. Rallies tracks SKIN analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is SKIN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SKIN. It does not provide personalized investment advice.
SKIN

SKIN